Pass, Harvey

Scientific Advances in Lung Cancer 2015

Tsao, A. S., Scagliotti, G. V., Bunn, P. A., Carbone, D. P., Warren, G. W., Bai, C., de Koning, H. J., Yousaf-Khan, A. U., McWilliams, A., Tsao, M. S., et al. (2016) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 284

Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

Akdemir, K. C., Le, V. T., Chandran, S., Li, Y., Verhaak, R. G., Beroukhim, R., Campbell, P. J., Chin, L., Dixon, J. R., Futreal, P. A., et al. (2020) · Nature Genetics

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 283

Programmed Necrosis Induced by Asbestos in Human Mesothelial Cells Causes High-Mobility Group Box 1 Protein Release and Resultant Inflammation

Yang, H., Rivera, Z., Jube, S., Nasu, M., Bertino, P., Goparaju, C., Franzoso, G., Lotze, M. T., Krausz, T., Pass, H. I., et al. (2010) · Proceedings of the National Academy of Sciences

Occupational and environmental lung diseasesCell death mechanisms and regulation

Cited by 281

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Tan, D. S. W., Yom, S. S., Tsao, M. S., Pass, H. I., Kelly, K., Peled, N., Yung, R. C., Wistuba, I. I., Yatabe, Y., Unger, M., et al. (2016) · Journal of Thoracic Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 201

The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival

Peters, B. A., Hayes, R. B., Goparaju, C., Reid, C., Pass, H. I., & Ahn, J. (2019) · Cancer Epidemiology, Biomarkers & Prevention

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 180

Germline BAP1 mutations induce a Warburg effect

Bononi, A., Yang, H., Giorgi, C., Patergnani, S., Pellegrini, L., Su, M., Xie, G., Signorato, V., Pastorino, S., Morris, P., et al. (2017) · Cell Death & Differentiation

Cancer, Hypoxia, and MetabolismChromatin Remodeling and Cancer

Cited by 133

Medical and Surgical Care of Patients with Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations

Carbone, M., Pass, H. I., Ak, G., Alexander, H. R., Baas, P., Baumann, F., Blakely, A. M., Bueno, R., Bzura, A., Cardillo, G., et al. (2022) · Journal of Thoracic Oncology

Occupational and environmental lung diseasesBRCA gene mutations in cancer

Cited by 97

Cellular and molecular parameters of mesothelioma

Ramos‐Nino, M. E., Testa, J. R., Altomare, D. A., Pass, H. I., Carbone, M., Bocchetta, M., & Mossman, B. T. (2006) · Journal of Cellular Biochemistry

Occupational and environmental lung diseasesIntraperitoneal and Appendiceal Malignancies

Cited by 71

Diagnosis and Prognosis-Review of Biomarkers for Mesothelioma

Sun, H. H., Vaynblat, A., & Pass, H. I. (2017) · Annals of Translational Medicine

Occupational and environmental lung diseasesIntraperitoneal and Appendiceal Malignancies

Cited by 55

Asbestos-Induced Chronic Inflammation in Malignant Pleural Mesothelioma and Related Therapeutic Approaches—A Narrative Review

Zolondick, A. A., Gaudino, G., Xue, J., Pass, H. I., Carbone, M., & Yang, H. (2021) · Precision Cancer Medicine

Occupational and environmental lung diseasesIntraperitoneal and Appendiceal Malignancies

Cited by 41

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma

Guo, Y., Chirieac, L. R., Bueno, R., Pass, H., Wu, W., Malinowska, I. A., & Kwiatkowski, D. J. (2014) · Oncogene

Occupational and environmental lung diseasesTGF-β signaling in diseases

Cited by 26